Gavin is 1 of 22 people chosen to trial a new ALS/MND drug designed to slow the progression of the disease.
For the first 6 months, the medication has helped Gavin. The results are good. Now the trial period has ended.
Until the drug is fully approved, the medicine must be privately funded. Gavin and his family are funding until January 2015.
It is time for us to join Gavin’s fight to LIVE LIFE.